Logo image of IPR.LS

IMPRESA SGPS SA (IPR.LS) Stock Fundamental Analysis

ELI:IPR - Euronext Lisbon - PTIPR0AM0000 - Common Stock - Currency: EUR

0.137  0 (0%)

Fundamental Rating

2

Overall IPR gets a fundamental rating of 2 out of 10. We evaluated IPR against 62 industry peers in the Media industry. IPR may be in some trouble as it scores bad on both profitability and health. IPR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

IPR had negative earnings in the past year.
In the past year IPR had a positive cash flow from operations.
In multiple years IPR reported negative net income over the last 5 years.
Of the past 5 years IPR 4 years had a positive operating cash flow.
IPR.LS Yearly Net Income VS EBIT VS OCF VS FCFIPR.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.49%, IPR is doing worse than 66.13% of the companies in the same industry.
IPR has a worse Return On Equity (-1.25%) than 66.13% of its industry peers.
IPR has a Return On Invested Capital (4.50%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.49%
ROE -1.25%
ROIC 4.5%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPR.LS Yearly ROA, ROE, ROICIPR.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

Looking at the Operating Margin, with a value of 6.78%, IPR is in line with its industry, outperforming 51.61% of the companies in the same industry.
IPR has a Gross Margin of 35.63%. This is in the lower half of the industry: IPR underperforms 67.74% of its industry peers.
Industry RankSector Rank
OM 6.78%
PM (TTM) N/A
GM 35.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPR.LS Yearly Profit, Operating, Gross MarginsIPR.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

IPR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
IPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IPR.LS Yearly Shares OutstandingIPR.LS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
IPR.LS Yearly Total Debt VS Total AssetsIPR.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.41, we must say that IPR is in the distress zone and has some risk of bankruptcy.
IPR has a worse Altman-Z score (0.41) than 72.58% of its industry peers.
The Debt to FCF ratio of IPR is 8.71, which is on the high side as it means it would take IPR, 8.71 years of fcf income to pay off all of its debts.
IPR has a Debt to FCF ratio (8.71) which is in line with its industry peers.
IPR has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.40, IPR is doing good in the industry, outperforming 62.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 8.71
Altman-Z 0.41
ROIC/WACC0.91
WACC4.95%
IPR.LS Yearly LT Debt VS Equity VS FCFIPR.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.3 Liquidity

IPR has a Current Ratio of 0.35. This is a bad value and indicates that IPR is not financially healthy enough and could expect problems in meeting its short term obligations.
IPR's Current ratio of 0.35 is on the low side compared to the rest of the industry. IPR is outperformed by 87.10% of its industry peers.
IPR has a Quick Ratio of 0.35. This is a bad value and indicates that IPR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of IPR (0.35) is worse than 87.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
IPR.LS Yearly Current Assets VS Current LiabilitesIPR.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for IPR have decreased strongly by -3326.09% in the last year.
Looking at the last year, IPR shows a small growth in Revenue. The Revenue has grown by 0.58% in the last year.
IPR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.25% yearly.
EPS 1Y (TTM)-3326.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3061.6%
Revenue 1Y (TTM)0.58%
Revenue growth 3Y-1.23%
Revenue growth 5Y0.25%
Sales Q2Q%0.11%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPR.LS Yearly Revenue VS EstimatesIPR.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IPR.LS Yearly EPS VS EstimatesIPR.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 0.02 0.04 0.06

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IPR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPR.LS Price Earnings VS Forward Price EarningsIPR.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

IPR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IPR is cheaper than 98.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.34
EV/EBITDA N/A
IPR.LS Per share dataIPR.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IPR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMPRESA SGPS SA

ELI:IPR (6/30/2025, 7:00:00 PM)

0.137

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-05 2025-03-05
Earnings (Next)07-22 2025-07-22
Inst Owners1.78%
Inst Owner ChangeN/A
Ins Owners1.51%
Ins Owner ChangeN/A
Market Cap23.02M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF 1.34
P/OCF 1.28
P/B 0.15
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY74.52%
OCF(TTM)0.11
OCFY78.04%
SpS1.08
BVpS0.91
TBVpS-0.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.49%
ROE -1.25%
ROCE 5.7%
ROIC 4.5%
ROICexc 4.64%
ROICexgc N/A
OM 6.78%
PM (TTM) N/A
GM 35.63%
FCFM 9.42%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 8.71
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.45%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.41
F-ScoreN/A
WACC4.95%
ROIC/WACC0.91
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3326.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3061.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.58%
Revenue growth 3Y-1.23%
Revenue growth 5Y0.25%
Sales Q2Q%0.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y173.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.89%
OCF growth 3YN/A
OCF growth 5YN/A